How rheumatoid arthritis is treated

Rheumatoid arthritis (RA) treatment focuses on slowing joint damage, reducing pain, and keeping you moving. The main approach uses disease-modifying antirheumatic drugs (DMARDs), which work by calming the immune system itself rather than just masking symptoms. Most people start with methotrexate, often combined with other DMARDs or with newer drugs called biologics that target specific parts of the immune response. The goal is to reach remission or low disease activity — meaning minimal inflammation and little to no new joint damage on X-rays.

Treatment usually starts early, within weeks of diagnosis, because the first months matter most for preventing permanent joint damage. Your rheumatologist will adjust your medications based on blood tests, imaging, and how you feel, aiming to find the combination that works best for your body. This is not a one-time prescription; RA treatment is ongoing and changes as your disease responds.

Key Takeaways

  • DMARDs and biologics are the foundation of RA treatment and work by slowing immune system activity, not just relieving pain.
  • Starting treatment early — within weeks of diagnosis — significantly reduces the risk of permanent joint damage.
  • Your rheumatologist adjusts medications based on blood work and imaging every few months until inflammation is controlled.
  • Most people take multiple medications together, and finding the right combination takes time and monitoring.
  • Physical therapy, rest during flares, and lifestyle changes support medication but do not replace it.

DMARDs: The first-line medications

Methotrexate is the most common starting DMARD because it works well, has a long track record, and costs less than newer options. You take it once a week by mouth or injection, and it takes 6 to 12 weeks to show full effect. Your doctor will order blood tests every 4 to 8 weeks at first to watch for side effects on your liver and blood counts.

If methotrexate alone does not control your inflammation enough, your rheumatologist typically adds a second DMARD — often hydroxychloroquine or sulfasalazine — rather than switching to something else. This combination approach works better than any single drug for many people. Some rheumatologists now add a biologic from the start if inflammation is severe or if you have other risk factors for joint damage.

DMARDs take weeks to work, so your doctor may also prescribe a short course of corticosteroids (like prednisone) to control pain and swelling while you wait for the DMARD to kick in. Corticosteroids are not a long-term solution — they carry risks with extended use — but they bridge the gap in those early weeks.

Biologics and newer targeted drugs

Biologics are made from living cells and target specific parts of the immune system driving RA. The main types block TNF-alpha (drugs like adalimumab, etanercept, infliximab) or block IL-6 (tocilizumab) or target T cells (abatacept). They work faster than traditional DMARDs — often within 2 to 4 weeks — and many people achieve remission on biologics who did not on methotrexate alone.

Biologics are given by injection or infusion, usually every 1 to 4 weeks depending on the drug. They cost significantly more than methotrexate but are often covered by insurance when methotrexate has been tried first. Because they suppress immune function, you will need screening for tuberculosis and hepatitis before starting, and you cannot receive live vaccines while on them.

JAK inhibitors are a newer class that block specific enzymes involved in immune signaling. Baricitinib and tofacitinib are taken by mouth daily and work similarly to biologics in controlling inflammation. They may be chosen if you prefer pills to injections or if biologics have not worked.

Managing pain and inflammation while medications work

Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen reduce pain and swelling but do not slow disease progression. They are useful short-term while DMARDs take effect, but long-term NSAID use carries risks for stomach ulcers and heart problems, especially in older adults. Your doctor may recommend taking them with a stomach protector if you need them regularly.

Acetaminophen handles pain without the inflammation-fighting effect, so it is gentler on the stomach but less effective for RA specifically. Many people use it alongside NSAIDs or as their main pain reliever if NSAIDs are not tolerated.

During flares — periods when inflammation spikes — rest, ice, and elevation help. Some people find that wearing a splint on an inflamed joint at night reduces morning stiffness. These are comfort measures, not treatments, but they matter for getting through difficult days.

Physical therapy and lifestyle support

Physical therapy helps maintain joint range of motion and muscle strength, which protects joints from further damage. A physical therapist can show you exercises that are safe during flares and more challenging ones when inflammation is controlled. Regular, gentle movement — walking, swimming, or tai chi — is better than rest for most people with RA, even though it feels counterintuitive during a flare.

Heat before exercise and ice after can ease stiffness and soreness. Occupational therapy teaches you how to do daily tasks — opening jars, buttoning clothes, gripping — in ways that do not stress damaged joints. Weight management reduces stress on weight-bearing joints like knees and hips.

Sleep matters: poor sleep worsens inflammation and pain. If RA pain keeps you awake, talk to your rheumatologist about adjusting medication timing or dose rather than accepting sleepless nights as part of the condition.

Monitoring and adjusting treatment

Your rheumatologist will see you every 4 to 12 weeks at first, depending on how new your diagnosis is and how well your current medications are working. At each visit, you will have blood work — typically a test called ESR (erythrocyte sedimentation rate) or CRP (C-reactive protein) to measure inflammation, and sometimes imaging like X-rays or ultrasound to check for new joint damage.

The goal is to reach remission (no signs of active inflammation) or low disease activity (minimal inflammation and no new damage). If you are not there after 3 months on a medication, your rheumatologist will increase the dose, add another drug, or switch to something different. This is normal and expected — finding the right treatment often takes several tries.

Once inflammation is controlled, visits space out to every 3 to 6 months. If you stay in remission for a year or more, some rheumatologists cautiously reduce medication doses, though this is done slowly and with close monitoring because RA often flares again if drugs are stopped.

What to ask your rheumatologist

When you start treatment, ask: What is the goal of this medication, and how long before I should see improvement? What side effects should I watch for, and which ones mean I should call you? How often will we check blood work, and what are we looking for? If this medication does not work, what is the next step?

Ask about pregnancy plans if that applies to you — some RA drugs are safe during pregnancy and some are not, and planning ahead matters. Ask whether you need any vaccines before starting a biologic. Ask what to do if you get sick or need surgery while on your current medications.

Bring a list of all other medications and supplements you take, because some interact with RA drugs. If cost is a concern, ask about generic versions, patient information programs, or whether a different drug might be covered by your insurance.

When to seek urgent care

Call your rheumatologist right away if you develop signs of infection — fever, chills, cough, or burning with urination — because biologics and some DMARDs lower infection risk. Seek emergency care if you have chest pain, shortness of breath, or severe abdominal pain, as these can signal serious side effects.

Contact your doctor if a new joint suddenly swells or becomes very painful, if you develop a rash, or if you have unusual bruising or bleeding. These can signal that your current medication is not working or that a side effect has developed. Do not stop taking your medication on your own; call first and ask what to do.

Frequently Asked Questions

How long does it take for RA medications to work?

DMARDs like methotrexate take 6 to 12 weeks to show their full effect, though you may notice some improvement earlier. Biologics and JAK inhibitors work faster, often within 2 to 4 weeks. Corticosteroids work within days but are used short-term only. If you are not seeing improvement after 3 months, your doctor will adjust your treatment.

Can RA go into remission?

Yes. With modern medications, 30 to 50 percent of people achieve remission — meaning no signs of active inflammation and no new joint damage. Even those who do not reach full remission often reach low disease activity, where symptoms are minimal and damage slows dramatically. Remission is the goal of treatment from the start.

What happens if my first medication does not work?

Your rheumatologist will adjust the dose, add a second medication, or switch to a different drug. This is expected and normal — RA treatment is individualized, and what works for one person may not work for another. Most people find an effective combination within 6 to 12 months of starting treatment.

Do I have to take RA medication forever?

Most people stay on RA medications long-term because stopping them usually causes the disease to flare again. However, if you reach remission and stay there for a year or more, your rheumatologist may try slowly reducing doses under close monitoring. The decision depends on how stable your remission is and your individual risk factors.

Can I stop taking my RA medication if I feel better?

No. Feeling better usually means the medication is working, not that you no longer need it. Stopping RA drugs on your own almost always leads to flares and can allow permanent joint damage to resume. If you want to reduce or stop medication, talk to your rheumatologist first — they can monitor you closely if a dose reduction is safe for your situation.